Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model

Heart

Volumn 86, Issue 1, 2001, Pages 81-87

  Du Toit, E ^a   Hofmann, D ^a   McCarthy, J ^a   Pineda, C ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b NATIONAL ACCELERATOR CENTRE   (South Africa)

Author keywords

Arrhythmias; Calcium sensitisers; Myocardial ischaemia

Indexed keywords

LEVOSIMENDAN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY LIGATION; DRUG EFFECT; HEART ARRHYTHMIA; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART OUTPUT; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; IN VIVO STUDY; MALE; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SWINE; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME;

EID: 0034769061     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.86.1.81     Document Type: Article

References (37)

1. Biochemical aspects of arrhythmogenesis and ventricular fibrillation
2. Do calcium-dependent ionic currents mediate ischemic ventricular fibrillation
3. A potential role of calcium ions in early ischemic and reperfusion arrhythmias
4. Role of calcium ions in reperfusion arrhythmias: Relevance to pharmacological intervention
5. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart
6. Effects of a calcium sensitizing positive inotropic agent MCI-154 and its combined use with analapril on post-ischaemic contractile dysfunction of dog hearts
7. Cardiovascular profile of the calcium sensitizer EMD 57033 in open chest anaesthetised pigs with regionally stunned myocardium
8. 2+ sensitisation predominantly enhances function and mechanical efficacy of stunned myocardium
9. Troponin C mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension
10. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation
11. The novel calcium sensitizer levosimendan activates the ATP-sensitive potassium channel in rat ventricular cells
12. + channel in rat arterial myocytes
13. Calcium sensitisation as a new principle of inotropic therapy in end-stage heart failure?
14. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium
15. Effects of a new calcium sensitiser, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting
16. Levosimendan enhances cardiac performance after cardiopulmonary bypass: A prospective, randomized placebo-controlled trial
17. Levosimendan: Effects of a calcium sensitizer on function and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff perfused guinea pig heart
18. Haemodynamic dose-efficacy of levosimendan in healthy volunteers
19. The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart
20. Distribution of myocardial blood flow before and after coronary artery ligation in the baboon. Relation to early ventricular fibrillation
21. Prevention of ventricular fibrillation by metoprolol in a pig model of acute myocardial ischemia: Absence of a major arrhythmogenic role for cyclic AMP
22. Combination of a calcium antagonist, verapamil, with an angiotensin converting enzyme inhibitor, trandolapril, in experimental myocardial ischaemia and reperfusion: Antiarrhythmic and hemodynamic effects of chronic oral pretreatment
23. Some statistical methods useful in circulation research
24. Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischemic "stunned" myocardium
25. Relationship between intracellular calcium and contractile force in stunned myocardium
26. Classification of positive inotropic actions based on electrophysiologic characteristics: Where should calcium sensitizers be placed?
27. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs
28. Pharmacokinetics of levosimendanosimendan in healthy volunteers and patients with congestive heart failure
29. 2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart
30. Protective effects of ATP sensitive potassium channel openers in models of myocardial ischemia
31. Effects of pinacidil combined with potassium cardioplegia on myocardial viability in hypothermic global ischemia followed by perfusion
32. A quantitative comparison of functional and anti-ischemic effects of the phosphodiesterase inhibitors amrinone, milrinone and levosimendan in rabbit isolated hearts
33. Regional myocardial ischemia: Characterisation of temporal, transmural and lateral flow interfaces in the porcine heart
34. Chronic oral pretreatment with the angiotensin converting enzyme inhibitor trandolapril decreases ventricular fibrillation in acute ischemia and reperfusion
35. Anaesthesia for cardiovascular research